Join to View Full Profile
4921 Parkview Pl# DvSt. Louis, MO 63110
Phone+1 800-647-2098
Fax+1 314-362-3192
Dr. Rohatgi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University in St. Louis School of MedicineClass of 2015
Certifications & Licensure
MO State Medical License 2021 - 2027
PA State Medical License 2018 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Neoadjuvant therapy for patients with nonsmall cell lung cancer: Not as easy in the real world.Giordano Fabricio Cittolin-Santos, Anjali Rohatgi
Cancer. 2026-02-15 - Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma.Lilit Karapetyan, Anthony R Cillo, Shuaichao Wang, Arivarasan Karunamurthy, Ryan C Massa
Medrxiv. 2025-11-06 - A Pulmonary Nodule with an Unexpected Mutation Profile.Lulu Sun, Hannah R Krigman, Anjali Rohatgi, George Ansstas, Andrew E O Hughes
Clinical Chemistry. 2025-03-03
Press Mentions
Dysfunctional B Cells: New Cancer Immunotherapy TargetFebruary 20th, 2025- Scientists Identify a New Cancer Immunotherapy Target: Dysfunctional B CellsFebruary 19th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
